Plenty of investors own International Business Machines Corp. (IBM) without ever buying a share. The 115-year-old company sits near the top of several tech dividend, Dow dividend and even quantum computing funds.
That hidden exposure got tested on Thursday, October 22, 2026. IBM beat Wall Street’s third-quarter estimates, yet its shares fell about 7% in morning trading, according to 24/7 Wall St. The trigger was not the numbers but one remark about how customers judge their AI bills.
On the earnings call, CEO Arvind Krishna said big enterprises now weigh the “true ROI” of their AI spending. He added that some worry the spending could run out of control without a real payoff. Investors heard customers reaching for the brakes.
Also read: IBM spent $11 billion on growth as its own software stalls
Those nerves trace back to July, when IBM suffered the worst single-day drop in its history, falling about 25%. Big deals slipped, and analysts said clients were redirecting budgets elsewhere, including servers and memory.
A handful of funds carry most of the IBM risk
About 557 ETFs hold IBM, according to Seeking Alpha, but most own only a sliver. The real exposure sits in a short list of income and quantum funds.
The First Trust NASDAQ Technology Dividend Index Fund (TDIV) had 8.65% of its assets in IBM as of October 21, according to First Trust. At that weight, a 7% slide in IBM trims roughly six-tenths of a point from the fund if nothing else moves. That stings, but it does not break a portfolio.
Quantum funds are the stranger case. The WisdomTree Quantum Computing Fund (WQTM) and Corgi Quantum Computing ETF (CQTM) both list IBM in their top 10, according to WisdomTree and Investing.com. People bought those funds for a moonshot, and on Thursday, they got a lesson in corporate IT budgets instead.
I think that overlap is the exposure most fund owners miss. A dividend ETF and a quantum ETF can quietly stack up a large IBM position, and both just reacted to the same sentence.
Fund owners can run these checks before reacting
Start with the fund’s own holdings page, since weights move daily and lists differ by source. TDIV also rebalances quarterly and caps single stocks, according to its prospectus, so an outsized IBM weight gets trimmed on schedule.
Then weigh concentration. The Vanguard High Dividend Yield ETF (VYM) had under 1% in IBM, which means less risk and a smaller rebound.
None of this calls for a quick trade. It does depend on what Krishna’s sentence actually meant.
NurPhoto / Getty Images
Krishna’s ROI warning doubles as a sales pitch
Read in full, the remark points somewhere else. Krishna argued that open-weight AI models now cost between 10% and 25% of what frontier models charge per token. He framed the choice as paying “10% of the cost if it’s 90% as good” as the leading systems.
That trade is IBM’s business. The company sells software, consulting and hybrid cloud tools that help big firms run cheaper models on their own servers. A customer that starts auditing its AI bill is exactly the customer IBM wants to meet.
I’d argue the market heard the first half of that thought and skipped the second. Accenture plc (ACN) slipped only about 0.5% and Infosys Ltd. (INFY) about 2% in the same session, 24/7 Wall St. reported. If investors truly feared an industry pullback, consulting rivals would have fallen harder.
That points to a credibility problem left over from July rather than a fresh demand problem. For dividend funds, the more telling number sat elsewhere in the report.
Dividend funds own IBM for its cash, which just grew
IBM raised its free cash flow outlook and now expects more than $1 billion of growth this year, according to its earnings release. Free cash flow is the cash left after running and investing in the business, and it is what pays the dividend.
That matters because dividend ETFs screen for payout durability, not for a one-day sentiment shift. IBM has paid a quarterly dividend every year since 1916, the company said, on top of a long dividend growth streak. It just declared another $1.69 per share, payable December 10.
More IBM:
- IBM, Amazon quantum pricing gets a challenger in Postquant Labs
- After a brutal slide, IBM sells smaller firms an ‘AI-ready’ core
- IBM just placed two very different tech bets in one day
Quarterly revenue also rose 5% to $17.1 billion, the release showed. If I owned TDIV, I would watch that cash flow line far more closely than Thursday’s share price. BofA’s read of the quarter was similarly calm.
BofA still sees IBM as a defensive holding
BofA Securities analyst Wamsi Mohan reiterated a Buy rating and a $280 price objective, according to a BofA research note shared with TheStreet. The October 22 note says about two-thirds of the deals that slipped out of the second quarter closed in the third.
Mohan’s team called IBM “a defensive story with improving growth and FCF trajectory.” Its bull points include Krishna’s cost argument: cheaper open-weight models should push more corporate AI onto company-owned systems, where IBM is well placed.
The bear case names the catch. BofA notes that about 3.5 points of software growth came from closing those delayed deals, so the underlying improvement was more modest.
December 10 now carries double weight. IBM pays its next dividend that day and hosts Quantum Day, which BofA flags as the stock’s next catalyst. Income investors and fans of Krishna’s quantum ambitions will be watching the same date for very different reasons.
The next few quarters will show whether companies keep auditing their AI bills or start spending freely again. Until then, tech dividend and quantum fund owners are exposed, and nobody yet knows whether that is a risk or a bargain.
More Stocks News
- Lockheed is spending its own money before Washington signs off
- Apple and Alphabet are sending Wall Street different signals
- Microsoft wants to keep more of its AI billions from Nvidia
- Stock Market Today (Oct. 23, 2026): Dow tumbles following tech sell-off
